Stage IV EGFR Lung Cancer Patient Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- EGFR-mutated
- Sex
- Female
- Treatment
- targeted therapy and supportive care
- Outcome
- Care Ongoing
Treatment course, step by step
- Leg swelling, whole-body swelling, heart-fluid concerns, CT imaging, and biopsy led to Stage IV EGFR-mutated lung cancer diagnosis
- Doctors discussed first-generation versus third-generation targeted therapy and possible later radiation if the tumor shrank
- Started first-generation targeted therapy on March 5
- By the interview, she had taken it for about 3 months
- Side effects included rash, itching, mouth sores, and skin symptoms treated with supportive medicines; Chinese medicine was also used
- No specific EGFR drug name or completed radiation was reported.
What happened, in summary
This unnamed woman’s lung cancer journey began with leg swelling. She first received water-reducing medication, but the swelling continued and eventually involved more of her body. Doctors became concerned about her heart, found fluid around the heart area, and arranged further imaging. A CT scan showed a suspicious lung lesion, and she was told to return for tissue sampling. Plans changed quickly when cancer markers suggested a tumor problem, and she was referred to oncology. The diagnosis was Stage IV EGFR-mutated lung cancer. Targeted therapy is central to the story, but the specific EGFR drug is not named. Doctors discussed first-generation and third-generation targeted options. Because the tumor was near the heart, radiation was discussed as something that might be arranged later if the tumor became smaller, but completed radiation was not reported. She chose or started first-generation targeted therapy on 5 March and had been taking it for about 3 months by the interview. Side effects appeared quickly, including acne-like sores, itching, mouth sores, and other skin symptoms. Her doctors provided supportive medicines and creams, and she also used Chinese medicine for symptom support. As of November 2025, she was still in active care and learning to live with Stage IV EGFR-mutated lung cancer.
Where this story comes from
This is a lay summary of an account first published by YouTube (ZH search). Read the original in full
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team.